Biodesix, Inc.
NASDAQ:BDSX
1.37 (USD) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Biodesix, Inc. |
Symbool | BDSX |
Munteenheid | USD |
Prijs | 1.37 |
Beurswaarde | 199,289,790 |
Dividendpercentage | 0% |
52-weken bereik | 1.15 - 2.21 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Scott Hutton |
Website | https://www.biodesix.com |
An error occurred while fetching data.
Over Biodesix, Inc.
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)